DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sergliflozin etabonate
Sergliflozin etabonate
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Įsakymas
Natural Products As Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose
An Emerging Protagonist: Sodium Glucose Co-Transporters (Sglts)
A Review on Evolution in Triglyceride Determination
Exploring Glycosuria As a Mechanism for Weight and Fat Mass Reduction. a Pilot Study with Remogliflozin Etabonate and Sergliflozin Etabonate in Healthy Obese Subjects
PKB XXVI 2018 Pendidikan Kedokteran Berkelanjutan (PKB) XXVI Ilmu Penyakit Dalam FK UNUD/RSUP Sanglah 2018
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Reniva Monograph
Impact of the 8-Week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus
Downloaded From
Descargar Revista Completa
Drugs in Pipeline for Type-2 Diabetes R Mahajan, K Gupta
Pharmaabkommen A1 E
Safety, Pharmacokinetics and Pharmacodynamics of Remogliflozin
SGLT2 Inhibitor Therapy Improves Blood Glucose but Does Not Prevent Diabetic Bone Disease in Diabetic DBA/2J Male Mice Kathryn M
Appendix – Literature Search & In-Excluded Studies
SGLT-2 Inhibitors: a New Mechanism for Glycemic Control
Top View
2012/062698 Al
Effect of Sodium Glucose Cotransporter 2 Inhibitors on Cardiac Function and Cardiovascular Outcome: a Systematic Review Koichiro Matsumura* and Tetsuro Sugiura
Empagliflozin, a Novel Selective Sodium Glucose Cotransporter2
Burden of Disease in 2013 Type 2 DM Glucose Management Goals
Sodium Glucose Co-Transporters (Sglts) As a Burgeoning Target for the Treatment of Diabetes Mellitus
(12) United States Patent (10) Patent No.: US 8,841,290 B2 Schwink Et Al
A Complete Review of Empagliflozin
Assessment of Remogliflozin Etabonate, a Sodium-Dependent
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/QSM/2009.3
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
WO 2017/198177 Al 23 November 2017 (23.11.2017) W !P O PCT